A HISTORY OF GLOBAL SOLUTIONS
The Jean Boulle Group acquires promising assets and projects and optimizes their structure, management and development with private and public investment.
NEWS AND MEDIA
September 16 2020 - Conservationists from Durrell Wildlife Conservation Trust, Mauritian Wildlife Foundation (MWF), BirdLife International, National Parks and Conservation Service of Mauritius (NPCS), and Forestry Service have enabled the emergency rescue of three species of rare reptiles, which might otherwise be facing extinction, following the Wakashio oil spill in Mauritius. [...]
September 1 2020
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Therapeutics, notes the results of a clinical trial1 (“the Trial”) published in Cell showing that trained immunity through the use of BCG vaccination can reduce respiratory tract infections by 80% amongst elderly people including, potentially, COVID-19. [...]
Jean Boulle Medtech’s New Therapeutics Technology Platform Targets Trained Immunity for COVID-19 Patients and Resultant Acute Respiratory Distress Syndrome
April 27 2020
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Medtech, is testing a unique strategy for treating Acute Respiratory Distress Syndrome1 (“ARDS”), which could prove to be highly effective in saving the lives of COVID–19 patients. [...]
Copyright © 2019 Jean Boulle Group. All rights reserved.